The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Pathogenic implications of iron accumulation in multiple sclerosis
Open accessAbstract
J. Neurochem. (2012) 120, 7–25. Iron, an essential element used for a multitude of biochemical reactions, abnormally accumulates in the CNS of patients with multiple sclerosis (MS). The mechanisms of abnormal iron deposition in MS are not fully understood, nor do we know whether these deposits have adverse consequences, that is, contribute to pathogenesis. With some exceptions, excess levels of iron are represented concomitantly in multiple deep gray matter structures often with bilateral representation, whereas in white matter, pathological iron deposits are usually located at sites of inflammation that are associated with veins. These distinct spatial patterns suggest disparate mechanisms of iron accumulation between these regions. Iron has been postulated to promote disease activity in MS by various means: (i) iron can amplify the activated state of microglia resulting in the increased production of proinflammatory mediators; (ii) excess intracellular iron deposits could promote mitochondria dysfunction; and (iii) improperly managed iron could catalyze the production of damaging reactive oxygen species (ROS). The pathological consequences of abnormal iron deposits may be dependent on the affected brain region and/or accumulation process. Here, we review putative mechanisms of enhanced iron uptake in MS and address the likely roles of iron in the pathogenesis of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional architecture of basal ganglia circuits: neural substrates of parallel processing
Alexander, G. E., & Crutcher, M. D. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90107-l · Cited by 4,131
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403 · cited 2×
“1999; Bjartmar and Trapp 2001; Dutta and Trapp 2011) and neurite and neuronal loss (Peterson et al. 2001; Vercellino et al. 2005; Dutta and Trapp 2007) can occur in addition to or in the absence of obvious cellular inflammation or ongoing demyelination.”
BackgroundVEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9369 · Cited by 1,296 · cited 1×
“VEGF enhances BBB leakage and induces angiogenesis (Zhang et al. 2000; Kaur and Ling 2008).”
BackgroundSindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S., Qi, Y., Schlecht, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44490 · Cited by 1,100 · cited 2×
“Macrophages are also susceptible to changes in iron concentrations, that is, increases in iron lead to the activation of NF-jB and an increase in ROS and cytokine production (Crichton et al. 2002; Sindrilaru et al. 2011).”
BackgroundRegulation of cellular iron metabolism
Wang, J., & Pantopoulos, K. (2011) · Biochemical Journal · doi:10.1042/bj20101825 · Cited by 986
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985 · cited 1×
“For instance, vessel alterations can be induced as a consequence of an overall autoimmune response directed to myelin antigens (McFarland and Martin 2007).”
BackgroundVirtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621 · cited 2×
“If hypoxic conditions develop in MS as suggested (Aboul-Enein et al. 2003; Lassmann 2003; Mahad et al. 2008b; Trapp and Stys 2009; Cunnea et al. 2011), then the response by DMT1 and by the transferrin receptor (discussed above) could facilitate the cellular uptake of iron.”
BackgroundCellular distribution of transferrin, ferritin, and iron in normal and aged human brains
Connor, J. R., Menzies, S. L., Martin, S. M. S., & Mufson, E. J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270421 · Cited by 472
Salazar, J., Mena, N., Hunot, S., Prigent, A., Alvarez-Fischer, D., Arredondo, M., Duyckaerts, C., Sazdovitch, V., Zhao, L., Garrick, L. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804373105 · Cited by 409
Mitochondrial defects in acute multiple sclerosis lesions
Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406 · cited 24×
“This stress could allow mitochondria to become dysfunctional resulting in excess production of ROS (Mahad et al. 2008a; Mao and Reddy 2010).”
InfluentialThe TIM gene family: emerging roles in immunity and disease
Kuchroo, V. K., Umetsu, D. T., DeKruyff, R. H., & Freeman, G. J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1111 · Cited by 388
Identification of a hypoxia response element in the transferrin receptor gene
Lok, C. N., & Ponka, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24147 · Cited by 380
Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes
Matute, C., Sánchez-Gómez, M. V., Martínez-Millán, L., & Miledi, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8830 · Cited by 352 · cited 1×
“Aside from neurons, NMDA receptors are expressed by oligodendrocytes (Wong 2006) and glutatmate excitotoxicity mediates oligodendrocyte cell death (Matute et al. 1997; Matute 2011).”
BackgroundCharacterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging
Haacke, E. M., Makki, M., Ge, Y., Maheshwari, M., Sehgal, V., Hu, J., Selvan, M., Wu, Z., Latif, Z., Xuan, Y., et al. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21676 · Cited by 329 · cited 17×
“Besides occasional exceptions (Russo et al. 1997), abnormal iron deposits in white matter are not thought to have bilateral spatial representations in both hemispheres, unlike the findings for deep gray matter structures (Russo et al. 1997; Haacke et al. 2009, 2010a; Khalil et al. 2009).”
BackgroundMethodInfluentialTakeuchi, H., Mizuno, T., Zhang, G., Wang, J., Kawanokuchi, J., Kuno, R., & Suzumura, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413863200 · Cited by 285 · cited 1×
“As mentioned earlier, iron amplifies the activated state of macrophages/microglia, and these activated cells can negatively impact neurons (Bartnik et al. 2000; Roediger and Armati 2003; Takeuchi et al. 2005; Brown and Neher 2010; Centonze et al. 2010).”
BackgroundIron in innate immunity: starve the invaders
Ganz, T. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.011 · Cited by 284 · cited 2×
“extracellular iron availability to bacteria (Ganz 2009).”
BackgroundLaw, M., Saindane, A. M., Ge, Y., Babb, J. S., Johnson, G., Mannon, L. J., Herbert, J., & Grossman, R. I. (2004) · Radiology · doi:10.1148/radiol.2313030996 · Cited by 242
Review: Mitochondria and disease progression in multiple sclerosis
Mahad, D., Lassmann, H., & Turnbull, D. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00987.x · Cited by 193
HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation
Bianchi, L., Tacchini, L., & Cairo, G. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.21.4223 · Cited by 189
Perivascular iron deposition and other vascular damage in multiple sclerosis.
Adams, C. W. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.2.260 · Cited by 178 · cited 23×
“Perivascular iron deposits, revealed by histochemistry, were associated with active or inactive lesions in 17% and 30% of MS subjects, respectively (Adams 1988); however, these frequencies may be under represented because of technical considerations related to tissue processing (LeVine 1997; LeVine…”
BackgroundInfluentialIron, Oxidative Stress and Early Neurological Deterioration in Ischemic Stroke
Carbonell, T., & Rama, R. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707780363014 · Cited by 147
Tacchini, L., Gammella, E., De Ponti, C., Recalcati, S., & Cairo, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800365200 · Cited by 132
Mehindate, K., Sahlas, D. J., Frankel, D., Mawal, Y., Liberman, A., Corcos, J., Dion, S., & Schipper, H. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00354.x · Cited by 129 · cited 2×
“In other models, DMT1 expression was up-regulated for a sustained period, that is, 2 months, in astrocytes following exposure to kainate (Huang et al. 2006), and glia accumulate iron within mitochondria following exposure to proinflammatory cytokines (Mehindate et al. 2001).”
BackgroundInhibition of autoimmune neuropathological process by treatment with an iron-chelating agent.
Bowern, N., Ramshaw, I. A., Clark, I. A., & Doherty, P. C. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1532 · Cited by 119
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer’s disease
Lassmann, H. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0607-8 · Cited by 112
MRI T2 shortening (‘black T2’) in multiple sclerosis: frequency, location, and clinical correlation
Bakshi, R., Shaikh, Z. A., & Janardhan, V. (2000) · NeuroReport · doi:10.1097/00001756-200001170-00004 · Cited by 92 · cited 11×
“In support of this view, several studies indicate a pathogenic role of oxidative damage in MS (LeVine and Chakrabarty 2004) and the level of iron deposition correlates with markers of disease progression (Bakshi et al. 2000; Bermel et al. 2005; Tjoa et al. 2005; Brass et al. 2006a; Zhang et al. 2007; Neema et al. 2009…”
BackgroundResultInfluentialCunnea, P., Mháille, A. N., McQuaid, S., Farrell, M., McMahon, J., & FitzGerald, U. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511399114 · Cited by 90 · cited 3×
“2007) resulting in a hypoxic state (Aboul-Enein et al. 2003; Lassmann 2003; Mahad et al. 2008b; Trapp and Stys 2009; Cunnea et al. 2011).”
BackgroundSerum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients
Sfagos, C., Makis, A. C., Chaidos, A., Hatzimichael, E. C., Dalamaga, A., Kosma, K., & Bourantas, K. L. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1171oa · Cited by 84
Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice
Pedchenko, T. V., & LeVine, S. M. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00256-7 · Cited by 78 · cited 4×
“In mice with experimental autoimmune encephalomyelitis (EAE), iron histochemical staining is typically associated with vessels, reactive microglia, and macrophages, although granular deposits and extravasated RBCs are also labeled (Forge et al. 1998; Pedchenko and LeVine 1998).”
BackgroundResultSelf-citationIron-deficient mice fail to develop autoimmune encephalomyelitis
Grant, S. M., Wiesinger, J. A., Beard, J. L., & Cantorna, M. T. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.8.2635 · Cited by 78 · cited 1×
“In contrast, a low iron diet has been shown to impair the ability of mice to develop EAE and it was proposed that the iron deficiency disrupted the development of T cells that are necessary for the disease process (Grant et al. 2003).”
BackgroundZamboni, P., Scapoli, G., Lanzara, V., Izzo, M., Fortini, P., Legnaro, R., Palazzo, A., Tognazzo, S., & Gemmati, D. (2005) · Dermatologic Surgery · doi:10.1097/00042728-200506000-00005 · Cited by 44
Cited by
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker
Wang, Y., & Liu, T. (2015) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25358 · Cited by 878
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Iron and neurodegeneration in the multiple sclerosis brain
Hametner, S., Wimmer, I., Haider, L., Pfeifenbring, S., Brück, W., & Lassmann, H. (2013) · Annals of Neurology · doi:10.1002/ana.23974 · Cited by 519
van der Poel, M., Ulas, T., Mizee, M. R., Hsiao, C.-C., Miedema, S. S. M., Adelia, Schuurman, K. G., Helder, B., Tas, S. W., Schultze, J. L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08976-7 · Cited by 306
Metadata
- Authors
- Williams, R., Buchheit, C. L., Berman, N. E. J., & LeVine, S. M.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2011-11-11
- Volume
- 120
- Issue
- 1
- Pages
- 7-25
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1657532570
- Cited by
- 167
- References
- 32
- FWCI
- 9.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.